MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
SIBN - SI-BONE Inc
$29.05
-2.95(-9.22%)8:22:20 PM 1/27/2021
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was founded in 2008 and is headquartered in Santa Clara, California.
Stock Chart

Summary:

  • MACD is crossing MACD signal line at 0.2. MACD crossing signal line is bullish signal.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news

    01/17/2021SIBN
    These 3 “Strong Buy” Stocks Are Top Picks for 2021, Say Analysts

    Some traditions are too time-honored to shirk, and on Wall Street, the annual ‘top picks’ are one. Usually made at the very end or very beginning of a year, the Street’s analysts publish reviews on the stocks they believe will show the best performance in coming months – their top picks. The analysts have been analyzing each stock carefully, looking at its past and current performance, its trends on a variety of time frames, management’s plans – they take everything into account. Their recommend...

    01/7/2021SIBN
    SI-BONE Announces Senior Leadership Changes and Record Quarterly Revenue

    Laura Francis to Become Chief Executive Officer; Jeff Dunn to Become Executive Chairman;  and Tony Recupero to Become President.SANTA CLARA, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE” or the “Company”), a Silicon Valley-based medical device company focused on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy, today announced its intention to appoint Laura Francis as Chief Executive Officer and to the board of ...

    01/4/2021SIBN
    SI-BONE, Inc. Announces that Updated ISASS Policy and Guidelines on MIS SI Joint Fusion Support Only Lateral Transiliac MIS Procedures

    SANTA CLARA, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that the International Society for the Advancement of Spine Surgery (ISASS) published an early view of its updated Policy on MIS Sacroiliac Joint Fusion (For Chronic Sacroiliac Joint Pain) in the December 2020 issue of the International Journal of Spine Surgery (https://www.ij...

    12/24/2020SIBN
    Is SIBN A Good Stock To Buy According To Hedge Funds?

    In this article we will check out the progression of hedge fund sentiment towards SI-BONE, Inc. (NASDAQ:SIBN) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 […]

    12/21/2020SIBN
    SI-BONE, Inc. Announces that Priority Health Became the 36th Payor with Exclusive iFuse Coverage Policy

    Updated Blue Cross Blue Shield Association Evidence Rating Supports only Triangular ImplantsSANTA CLARA, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that effective November 25, 2020, Priority Health Michigan became the 36th U.S. payor with an exclusive, positive iFuse coverage policy. Prior to its November 2020 update, the Priority ...

    12/17/2020SIBN
    SI-BONE to Present at the 23rd Annual Needham Growth Conference and the 39th Annual J.P. Morgan Healthcare Conference

    SANTA CLARA, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced today that the company will be participating in the upcoming 23rd Annual Needham Growth Conference and the 39th Annual J.P. Morgan Healthcare Conference. For the Needham Growth Conference, SI-BONE’s management is scheduled for a Fireside Chat on Monday, January 11, 2021 at 2:45 p.m. Eastern Time /...

    12/16/2020SIBN
    SI-BONE, Inc. Announces that Humana Establishes Exclusive Coverage for iFuse in MIS SI Joint Fusion Procedures

    Humana is one of the 5 largest commercial payors in the U.S. and joins 36 other commercial health plans that offer coverage for the triangular iFuse Implant System onlySANTA CLARA, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacro-pelvic anatomy, today announced that Humana has revised its coverage policies to cover minimally invasive SI joint fusion using triangular ti...

    11/4/2020SIBN
    SI-BONE, Inc. (NASDAQ:SIBN) Just Reported And Analysts Have Been Lifting Their Price Targets

    A week ago, SI-BONE, Inc. (NASDAQ:SIBN) came out with a strong set of third-quarter numbers that could potentially...